We are performing whole-genome sequencing of families with autism spectrum disorder (ASD)
to build a resource (MSSNG) for subcategorizing the phenotypes and underlying genetic …

Autism spectrum disorder (ASD) is genetically heterogeneous, with evidence for hundreds
of susceptibility loci. Previous microarray and exome-sequencing studies have examined …

Importance The use of genome-wide tests to provide molecular diagnosis for individuals with
autism spectrum disorder (ASD) requires more study. Objective To perform chromosomal …

Fully understanding autism spectrum disorder (ASD) genetics requires whole-genome
sequencing (WGS). We present the latest release of the Autism Speaks MSSNG resource, which …

De novo mutations (DNMs) are important in autism spectrum disorder (ASD), but so far
analyses have mainly been on the~ 1.5% of the genome encoding genes. Here, we performed …

Copy-number variations (CNVs) are strong risk factors for neurodevelopmental and psychiatric
disorders. The 15q13.3 microdeletion syndrome region contains up to ten genes and is …

Background The Xp22.11 locus that encompasses PTCHD1, DDX53, and the long noncoding
RNA PTCHD1-AS is frequently disrupted in male subjects with autism spectrum disorder (…

Identification of genetic biomarkers associated with autism spectrum disorders (ASDs) could
improve recurrence prediction for families with a child with ASD. Here, we describe clinical …

A challenge in clinical genomics is to predict whether copy number variation (CNV) affecting
a gene or multiple genes will manifest as disease. Increasing recognition of gene dosage …

To investigate age-related intrinsic regulation of the capacity of human fetal oligodendrocyte
progenitor cells (OPCs) to myelinate, potential OPCs were selected from 15- to 23-…